Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

The popular weight-loss and diabetes medication tirzepatide is no longer in short supply, the Food and Drug Administration said. Eli Lilly's tirzepatide, sold as Zepbound for weight loss and ...

Eli Lilly's tirzepatide set the bar for weight loss. In a study leading to Zepbound's approval, patients given the highest ...

Eli Lilly's tirzepatide set the bar for weight loss. In a study leading to Zepbound's approval, patients given the highest dosage of 15 mg per week were 20.9% lighter after 72 weeks. If CagriSema ...

Recently, new pharmaceutical innovations have reshaped the weight loss treatment landscape ... 5-mg or 5-mg doses for $399 and $549 per month. Can I use Zepbound and Ozempic together for better ...

Some fear weight-loss stocks are approaching bubble territory, but this incumbent player continues to prove its worth ...

Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year ... according to research presented this week at the Annual Meeting of The European ...

Ozempic is a once-weekly injection used to improve blood sugar levels in patients with Type 2 diabetes. It comes in doses of 0.25, 0.5, 1 and 2 milligrams (mg). The active ingredient, semaglutide ...